The Effect of Meglumine Cyclic Adenosine vs Milrinone on Cogestive Heart Fail- ure in Elderly Patients

Objective: To study the clinical effects of treating congestive heart failure with Meglumine Cyclic Adenosine vs Milrinone. Methods: 80 inpatients with congestive heart failure were randomly divided into two groups. (1) meglumine cyclic adenosme (40 cases), (2) milrinone (40 cases). Patients in first group received MCA (30 mg) in 5% glucose 20 ml via intravenous injection, then MCA (150 mg) + 5% glucose 250 ml was injected intravenously once a day. The second group received milrinone 2. 5 mg four times each day. Results: After one week's treatment, the total clinical effective rates for each group were 87. 5% and 82. 5% respectively, while the difference in the two groups was not significant (P0. 05). Conclusion: MCA is an effective medicine in treatment of elderly congestive heart failure.